Efficacy and safety of nab-paclitaxel plus s-1 in the first-line treatment of advanced pancreatic cancer.

Wen Zhang,Chun-Xia Du,Yongkun Sun,Lin Yang,Chengxu Cui,Zhichao Jiang,J Wang,Aiping Zhou

Efficacy and safety of nab-paclitaxel plus s-1 in the first-line treatment of advanced pancreatic cancer.

2018

Wen Zhang
Chun-Xia Du
Yongkun Sun
Lin Yang
Chengxu Cui
Zhichao Jiang
J Wang
Aiping Zhou

e16217Background: Gemcitabine has been approved as the standard chemotherapy for advanced pancreatic cancer since 1996. FOLFIRINOX significantly improved ORR and OS than GEM single-agent, but the s...

Keywords:

Nab-paclitaxel
Pancreatic cancer
Pathology
Oncology
Internal medicine
Medicine
Chemotherapy
FOLFIRINOX
Gemcitabine
first line treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations